Nanologix Stock Fundamentals
| NNLX Stock | USD 0.0001 0.00 0.00% |
Nanologix fundamentals help investors to digest information that contributes to Nanologix's financial success or failures. It also enables traders to predict the movement of Nanologix Pink Sheet. The fundamental analysis module provides a way to measure Nanologix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanologix pink sheet.
Nanologix |
Nanologix Company Return On Equity Analysis
Nanologix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nanologix Return On Equity | -2.14 |
Most of Nanologix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanologix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nanologix has a Return On Equity of -2.1357. This is 91.09% lower than that of the Healthcare sector and 94.14% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Nanologix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanologix's current stock value. Our valuation model uses many indicators to compare Nanologix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanologix competition to find correlations between indicators driving Nanologix's intrinsic value. More Info.Nanologix is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanologix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanologix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanologix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanologix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nanologix could also be used in its relative valuation, which is a method of valuing Nanologix by comparing valuation metrics of similar companies.Nanologix is currently under evaluation in return on equity category among its peers.
Nanologix Fundamentals
| Return On Equity | -2.14 | |||
| Return On Asset | -1.3 | |||
| Current Valuation | (166.24 K) | |||
| Shares Outstanding | 158.79 M | |||
| Price To Earning | (3.24) X | |||
| Price To Sales | 12.46 X | |||
| Revenue | 892 | |||
| Gross Profit | (99.13 K) | |||
| EBITDA | (1.79 M) | |||
| Net Income | (1.86 M) | |||
| Cash And Equivalents | 178.19 K | |||
| Current Ratio | 128.89 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | -33.55 | |||
| Market Capitalization | 15.88 K | |||
| Total Asset | 921.24 K | |||
| Z Score | -3.3 | |||
| Net Asset | 921.24 K |
About Nanologix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanologix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanologix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanologix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. Nanologix operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nanologix Pink Sheet Analysis
When running Nanologix's price analysis, check to measure Nanologix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanologix is operating at the current time. Most of Nanologix's value examination focuses on studying past and present price action to predict the probability of Nanologix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanologix's price. Additionally, you may evaluate how the addition of Nanologix to your portfolios can decrease your overall portfolio volatility.